US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

209.05

+0.10000.05%

Post-market: 209.800.7500+0.36%19:56 EDT

Volume:1.22M

Turnover:254.37M

Market Cap:10.53B

PE:33.12

High:209.84

Open:207.24

Low:206.01

Close:208.95

52wk High:217.12

52wk Low:138.79

Shares:50.35M

Float Shares:50.35M

Volume Ratio:0.90

T/O Rate:2.43%

Dividend:0.42

Dividend Rate:0.20%

EPS(TTM):6.31

EPS(LYR):-1.4940

ROE:24.54%

ROA:0.10%

PB:1.29

PE(LYR):-139.93

Loading ...

Overview Company News Filings

Vertex Advances Share Buyback, Acquires 445,500 Shares by August

Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run

Simply Wall St.

Actinogen Plans Major Share Placement to Bolster Funding Capacity

Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?

Simply Wall St.

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Circio boosts circVec gene therapy data and secures funding runway to 2030

iShares Biotechnology ETF Announces Q3 2026 Dividend of R$ 0.02 Per Unit

Sector Update: Healthcare Stocks Decline Monday Afternoon

MT Newswires Live

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US, Iran Exchange Attacks

MT Newswires Live

Political and General News Events from August 31

Sector Update: Healthcare

MT Newswires Live

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda receives FDA approval of NDA for Mimrylo

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/IBB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":209.05,"timestamp":1788206400000,"preClose":208.95,"halted":0,"volume":1222364,"hourTrading":{"tag":"盘后","latestPrice":209.8,"preClose":209.05,"latestTime":"19:56 EDT","volume":16405,"amount":3428644.0854,"timestamp":1788220595142,"change":0.75,"changeRate":0.003588,"amplitude":0.005166},"delay":0,"changeRate":0.00047858339315636633,"floatShares":50350000,"shares":50350000,"eps":6.311863,"marketStatus":"Not Yet Opened","change":0.1,"latestTime":"08-31 16:00:00 EDT","open":207.24,"high":209.84,"low":206.01,"amount":254372469.33956,"amplitude":0.01833,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":208.95,"sharesOutstanding":49450000,"nav":208.979543,"aum":10469875104.3,"dividendRate":0.001999,"bidAskSpread":0.000356,"preHourTrading":{"tag":"盘前","latestPrice":208,"preClose":208.95,"latestTime":"09:29 EDT","volume":1437,"amount":298884.70518,"timestamp":1788182999999,"change":-0.95,"changeRate":-0.004547,"amplitude":0.012868},"postHourTrading":{"tag":"盘后","latestPrice":209.8,"preClose":209.05,"latestTime":"19:56 EDT","volume":16405,"amount":3428644.0854,"timestamp":1788220595142,"change":0.75,"changeRate":0.003588,"amplitude":0.005166},"volumeRatio":0.899712,"impliedVol":0.243,"impliedVolPercentile":0.6653},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50350000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":0.899712,"shares":50350000,"dividePrice":0.4179,"high":209.84,"amplitude":0.01833,"preClose":208.95,"low":206.01,"week52Low":138.785,"pbRate":"1.29","psRate":"253.24","week52High":217.12,"institutionHeld":0,"latestPrice":209.05,"eps":6.311863,"divideRate":0.001999,"volume":1222364,"delay":0,"ttmEps":6.311863,"open":207.24,"prevYearClose":168.77,"prevWeekClose":208.95,"prevMonthClose":186.41,"prevQuarterClose":190.19,"fiveDayClose":212.53,"twentyDayClose":185.91,"sixtyDayClose":171.43},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664838571","title":"Vertex Advances Share Buyback, Acquires 445,500 Shares by August","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838571","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838571?lang=en_us&edition=fundamental","pubTime":"2026-09-01 12:22","pubTimestamp":1788236545,"startTime":"0","endTime":"0","summary":"Vertex Corp. ( ($JP:5290) ) has provided an announcement. Vertex Corporation reported the progress of its ongoing share buyback program, authorized...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-share-buyback-acquires-445500-shares-by-august?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PBE","LU2456880835.USD","LU1035775433.USD","BK4139","LU1430594728.SGD","ACKY","LU1069344957.HKD","LU0417517546.SGD","IE0002141913.USD","BRKC","GNMX","LU0061475181.USD","BK4588","IDNA","IE00BFTCPJ56.SGD","BRKD","LU1674673428.USD","LU1559883803.SGD","VRTX","BIB","LU2468319806.SGD","IBB","IBBQ","LU0320765992.SGD","LU0109394709.USD","VERX","BRKU","LU2362541513.USD","TBXU","IE00BZ9MQY76.HKD","BBH","LU0757428866.USD","BK4567","BRKW","LU0234570918.USD","SG9999001176.USD","ACTV","IE00BJJMRZ35.SGD","LU0058720904.USD","IE00B19Z9P08.USD","LU0889565916.HKD","LU2237438978.USD","LU1585245621.USD","LU2462157665.USD","BRKL","IE00BJT1NW94.SGD","LU0256863811.USD","LU1778281490.HKD","IE00B2B36J28.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664838493","title":"Vertex (VRTX) Stock Looks Reasonable As Growth Must Justify Its Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2664838493","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664838493?lang=en_us&edition=fundamental","pubTime":"2026-09-01 10:20","pubTimestamp":1788229256,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals has delivered strong long term gains over the past five years, yet current valuation checks suggest the stock now looks closer to fairly priced than clearly cheap. For investors, the question is how that past share price performance lines up with what the broader valuation signals are saying today.\n\nThe stock has returned 174.9% over five years, which puts extra focus on whether recent strength already reflects much of the good news in the story.\nFuture growth in cash...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/36235-main-header/1756253398031"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrtx/vertex-pharmaceuticals/news/vertex-vrtx-stock-looks-reasonable-as-growth-must-justify-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1559883803.SGD","IE00BJJMRZ35.SGD","GNMX","IE00B19Z3B42.SGD","BBH","LU1430594728.SGD","BK4139","LU0079474960.USD","IBBQ","LU0289739699.SGD","LU1815336091.USD","LU2362540622.SGD","SG9999001176.USD","LU2089984988.USD","BK4588","TSPA","VRTX","TBXU","PBE","LU0109394709.USD","LU1069344957.HKD","BK4532","IBB","LU0823416689.USD","SG9999001176.SGD","BIB","VERX","LU0061475181.USD","LU2417539215.USD","LU0432979614.USD","BK4585","LU1035775433.USD","LU1674673428.USD","IE0002141913.USD","IE00B19Z9Z06.USD","LU0234570918.USD","SGXZ57979304.SGD","LU1778281490.HKD","LU2324357040.USD","LU1674673691.USD","IE00BZ9MQY76.HKD","IDNA","TACU","CDIG","LU0566484027.USD","LU0889565916.HKD","LU1093756168.USD","IE0009355771.USD","IE00B19Z3581.USD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881767","title":"Actinogen Plans Major Share Placement to Bolster Funding Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881767","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881767?lang=en_us&edition=fundamental","pubTime":"2026-09-01 08:46","pubTimestamp":1788223606,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) just unveiled an update. Actinogen Medical Limited, an ASX-listed biotechnology company trading under the code ACW,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-plans-major-share-placement-to-bolster-funding-capacity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-plans-major-share-placement-to-bolster-funding-capacity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","AGNG","BBP","BK4588","FHLC","JDOC","XT","IEIH","DARP","BK4585","FWD","IBB","SYNB","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854881","title":"Is Pasatru’s Rare Disease Approval With Home Infusion Potential Altering The Investment Case For Regeneron Pharmaceuticals (REGN)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854881","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854881?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:17","pubTimestamp":1788218267,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals has secured past FDA approval for Pasatru (garetosmab-grts), a VelocImmune-derived monoclonal antibody that reduces new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, based on Phase 3 OPTIMA trial data.\nThis approval introduces a new rare disease therapy that can be infused monthly, including in home settings, and is supported by strong lesion-reduction outcomes against placebo while carrying...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/33715-main-header/1756202993919"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-regn/regeneron-pharmaceuticals/news/is-pasatrus-rare-disease-approval-with-home-infusion-potenti","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2468319806.SGD","LU0114720955.EUR","LU0320765992.SGD","LU0882574055.USD","LU0058720904.USD","LU2089984988.USD","LU2106854487.HKD","LU0053666078.USD","LU0823434740.USD","REGN","BK4585","IBB","HBCP","LU0823434583.USD","BK4139","CHAT","LU2362541273.HKD","ARTY","LU0109394709.USD","AGIX","LU1974910355.USD","LU2237438978.USD","LU2362541513.USD","TBXU","BK4588","BK4211","LU2023250504.SGD","BBH","LU0823416689.USD","IBBQ","BK4195","LU2362540622.SGD","LU0889565916.HKD","QTOC","LU0289739699.SGD","VTHR","LU1917777945.USD","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664925888","title":"Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2664925888","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664925888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:53","pubTimestamp":1788205998,"startTime":"0","endTime":"0","summary":"UPDATE 2-Trump administration announces drug pricing deals with CSL, Astellas and othersWASHINGTON, Aug 31 (Reuters)-U.S. President Donald Trump announced a new round of drug-pricing agreements with i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0RA:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","LU1983299246.USD","LU1057294990.SGD","BK0046","BK4550","300485","IE00BLSP4239.USD","LU2112291526.USD","SG9999002224.SGD","CSL.AU","BK4505","BK4534","LU0109394709.USD","IE00B3T34201.USD","BIB","LU1883839398.USD","LU0868494617.USD","LU1894683348.USD","IE00BLSP4452.SGD","BK0028","BBIO","IBBQ","BK4566","LU0320765992.SGD","688235","TBXU","BBH","PFE","LU2242646821.SGD","IE00BJT1NW94.SGD","BK4007","OZEM","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","PJP","AMGN","IE0002270589.USD","LU0225284248.USD","LU0889565916.HKD","IE0002141913.USD","LU0306806265.USD","SGXZ57979304.SGD","PBE","IBB","LU0321505439.SGD","BK7511","SG9999001176.SGD","LU2468319806.SGD","IONS","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664000711","title":"Circio boosts circVec gene therapy data and secures funding runway to 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2664000711","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664000711?lang=en_us&edition=fundamental","pubTime":"2026-09-01 03:03","pubTimestamp":1788203022,"startTime":"0","endTime":"0","summary":"The latest update is out from Targovax ASA ( ($GB:0RIS) ). Circio Holding ASA reported that new preclinical data show its circVec circular RNA tech...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-boosts-circvec-gene-therapy-data-and-secures-funding-runway-to-2030?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE0009354923.USD","BK4505","GNOM","IBB","BK4585","SYNB","FBT","TBXU","RNA","CNCR","IBBQ","LFSC","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664007498","title":"iShares Biotechnology ETF Announces Q3 2026 Dividend of R$ 0.02 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2664007498","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664007498?lang=en_us&edition=fundamental","pubTime":"2026-09-01 01:46","pubTimestamp":1788198368,"startTime":"0","endTime":"0","summary":"iShares Biotechnology ETF announces Q3 2026 dividend of R$ 0.02 per unitiShares Biotechnology ETF declared a 3Q 2026 cash distribution of BRL 0.02 per unit.Units trade with entitlement through Sept. 14.Payment is scheduled for Sept. 24.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iShares Biotechnology ETF published the original content used to generate this news brief on August 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL9CMGGK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664007127","title":"Sector Update: Healthcare Stocks Decline Monday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2664007127","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664007127?lang=en_us&edition=fundamental","pubTime":"2026-09-01 01:37","pubTimestamp":1788197856,"startTime":"0","endTime":"0","summary":"Healthcare stocks were lower Monday afternoon, with the NYSE Healthcare Index decreasing 0.5% and the State Street Health Care Select Sector SPDR ETF (XLV) down 0.4%.The iShares Biotechnology ETF (IBB","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2211815571.USD","LU0238689110.USD","HRTS","LU0882574055.USD","LU2237443465.HKD","LU2417539215.USD","LU0353189763.USD","SG9999013999.USD","LU0689472784.USD","LU1712237335.SGD","LU2023251221.USD","LU1868837136.USD","BK4585","LU0096364046.USD","THNR","LU1548497426.USD","IE00BWXC8680.SGD","LU2168564222.USD","ILDR","LU1917777945.USD","LU2087625088.SGD","SGXZ99366536.SGD","BK4007","LU2552382058.USD","IE0002141913.USD","LU2491050071.SGD","SG9999015978.USD","LU0158827948.USD","LU0203201768.USD","LU0094547139.USD","LU1988902786.USD","SGXZ51526630.SGD","LU0823434583.USD","LU2108987350.USD","LU2265009873.SGD","PJP","LU0820562030.AUD","LU1023059063.AUD","LU2361044865.SGD","LU0133085943.USD","LU2491050154.USD","LU0672654240.SGD","LU2746668974.SGD","LU0256863811.USD","BK4533","LU1804176565.USD","IE00B775H168.HKD","LU2168564065.EUR","LU0198837287.USD","OZEM","LU0820561818.USD","LU0889565916.HKD","IXJ","LU1267930730.SGD","LU2360106947.USD","VHT","LU1868836914.USD","LU2168564495.EUR","LU0417517546.SGD","MEDI","LU2237443382.USD","LU0114720955.EUR","CANC","LU0345770993.USD","LU0683600562.USD","LU0061475181.USD","CURE","IE00B1BXHZ80.USD","LU2756315318.SGD","IE00BFTCPJ56.SGD","SG9999018865.SGD","LU2089283258.USD","LU2756315664.SGD","BK4588","LU2028103732.USD","LU2324357040.USD","IE0004445015.USD","LU0210536198.USD","LU1974910355.USD","IYH","LU1057294990.SGD","LU2602419157.SGD","SG9999015986.USD","IE00BFSS7M15.SGD","LU0708995401.HKD","IE00BFSS8Q28.SGD","LU1979441026.SGD","LU2023250504.SGD","IE00B2B36J28.USD","LU2089284900.SGD","LU1093756325.SGD","LU2552382132.HKD","LU1629891620.HKD","SG9999018857.SGD","LU0471298694.HKD","LU2357305700.SGD","LU0079474960.USD","LU2264538146.SGD","LLII","LU1691799644.USD","LU1127390331.HKD","IE00BKDWB100.SGD","LLYZ","LU2456880835.USD","LU2491049909.HKD","LU0109391861.USD","LU2462157665.USD","IE0009355771.USD","LU0385154629.USD","LU1989771016.USD","LU0471298777.SGD","LU2089984988.USD","LLYX","LU0097036916.USD","LU0823434740.USD","LU0225283273.USD","GB00BDT5M118.USD","LU1145028129.USD","IE00BK4W5M84.HKD","LU2237443622.USD","LU2237438978.USD","LU1064131342.USD","ALVO","PPH","FTXH","SG9999015952.SGD","LU0266013472.USD","LU0456855351.SGD","LU1093756168.USD","LU2213496289.HKD","LU2361044949.HKD","JDOC","LU2023250330.USD","LU1868836591.USD","LU1323610961.USD","LU2106854487.HKD","MEDX","LU0787776722.HKD","IE00BKPKM429.USD","LU2111349929.HKD","IE0001KFT4U8.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","RXL","SGXZ31699556.SGD","LU0006306889.USD","LU0320765992.SGD","ELIS","LU1069344957.HKD","LU0823416689.USD","LU2237443549.SGD","LU0354030511.USD","MHIP","IE00B4R5TH58.HKD","LU2552382215.SGD","LU0820561909.HKD","SGXZ81514606.USD","LU0158827781.USD","LU0345770308.USD","SG9999014898.SGD","LU2750360997.AUD","GDOC","IE00BJJMRY28.SGD","LU1868837300.USD","SG9999017495.SGD","ELIL","LU0354030438.USD","LU0943347566.SGD","LU0964807845.USD","SG9999001176.SGD","BK4581","LU0432979614.USD","LU2112291526.USD","SG9999014914.USD","LU2462591350.SGD","BK4516","IE00B7KXQ091.USD","LABU","LU1720051108.HKD","LU1551013425.SGD","WDNA","LU2746668461.USD","TMED","TRUH","SGXZ57979304.SGD","LU2168564149.EUR","SG9999014906.USD","BK4534","IE00BN29S564.USD","LU0640476718.USD","LU2471134952.CNY","SG9999014880.SGD","IE00B1XK9C88.USD","IE0005OL40V9.USD","BK4139","LU2461242641.AUD","LU0122379950.USD","LU1035775433.USD","LU2471134879.HKD","IE00BJLML261.HKD","LU1868836757.USD","IE00BJJMRX11.SGD","IHE","LLY","XBI","LU1280957306.USD","SG9999001176.USD","LU0289739699.SGD","LU1232071149.USD","LU2237443895.HKD","LU0109394709.USD","LU1366192091.USD","LU1551013342.USD","LU2471134523.USD","LU0786609619.USD","LU2471134796.USD","AGNG","LU0058720904.USD","LU2168563687.JPY","LU2361045086.USD","LU2271345857.HKD","IE00B4JS1V06.HKD","LU0882574139.USD","LU1814569148.SGD","LU0320765059.SGD","LU2750360641.GBP","IBB","IE0004445239.USD","LU2236285917.USD","IE00BK4W5L77.USD","XLV","LU0174119429.USD","LU0256863902.USD","LU0353189680.USD","LU2468319806.SGD","FHLC","IE00BJT1NW94.SGD","BK4599","LU0323591593.USD","LU0203202063.USD","LU1720051017.SGD","LU1291159041.SGD","LU2237443978.SGD","LU2896262040.SGD","SG9999015945.SGD","LU1623119135.USD","LU1983299246.USD","LU0106261372.USD","LU0234572021.USD","LU0316494557.USD","LU2063271972.USD","LU0466842654.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663561006","title":"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US, Iran Exchange Attacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2663561006","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663561006?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:28","pubTimestamp":1788182880,"startTime":"0","endTime":"0","summary":"The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.3%, and the actively traded Invesco QQQ Trust (QQQ) retreated 0.2% in Monday's premarket activity as the US and Iran excha","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PCG.AU","XLF","PCG","SAIC","AON","IYJ","FDN","EETH","XSD","SPY.AU","BITO","RTH","XLE","XLV","SPY","IYH","SLV","DRTS","USO","VHT.AU","XRT","VDC","FAZ","BETH","QQQ","GME","IYK","FAS","IVV","VHT","XLP","EQR","XLI","RTH.AU","VIS","AON.AU","XLY","IYE","UNG","GLD","EXI","XLK","IYW","PMR","IBB","KKR","SOXX","SPCX","IGM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663005748","title":"Political and General News Events from August 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2663005748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663005748?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:15","pubTimestamp":1788182117,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 31Aug 31 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL4N44S10Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU2089984988.USD","PJP","LU2242652126.USD","IE0009355771.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","BK4534","LU1571399168.USD","IBB","LU0289739699.SGD","TBXU","LU0889565916.HKD","BK4533","IE00BJT1NW94.SGD","BIB","LU2468319806.SGD","LU0868494617.USD","BK4581","PBE","IE0002141913.USD","LU1023059063.AUD","BK4599","SG9999001440.SGD","BK4588","LU2112291526.USD","IBBQ","BBH","IE00BFTCPJ56.SGD","LU0058720904.USD","LU2242646821.SGD","AMGN","LU0122379950.USD","BK4585","LU1983299246.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","BK4139","LU1061106388.HKD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663200514","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2663200514","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663200514?lang=en_us&edition=fundamental","pubTime":"2026-08-31 21:04","pubTimestamp":1788181452,"startTime":"0","endTime":"0","summary":"Healthcare stocks were falling premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.5% lower and the iShares Biotechnology ETF (IBB) down 0.6%.Arrowhead Pharmaceuticals' ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","HCSG","IBB","BK4137","BK4585","XLV","XBI","ARWR","LU0128526141.USD","BK4581","LU0029874061.USD","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071381","title":"Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071381","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071381?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:51","pubTimestamp":1788169915,"startTime":"0","endTime":"0","summary":"Amgen  said Monday that its cholesterol-lowering drug Repatha reduced the risk of death by 20% in high-risk adults without a prior heart attack or stroke.The findings came from a pre-specified analysis of the phase 3 VESALIUS-CV trial involving more than 12,000 patients and were presented at the European Society of Cardiology Congress 2026 in Munich, it said.Amgen said Repatha reduced both overall and cardiovascular deaths when added to statins or other LDL-C-lowering treatments. The mortality benefit emerged after about 1.5 years and continued through a median follow-up of 4.6 years, it added.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU1057294990.SGD","BK4585","LU0289739699.SGD","LU0109394709.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","IE00B2B36J28.USD","LU0320765992.SGD","IE0002141913.USD","AMGN","IE00B4R5TH58.HKD","LU0058720904.USD","SG9999001440.SGD","PJP","IE0009355771.USD","LU2242652126.USD","LU1023059063.AUD","BK4581","BBH","BK4566","LU2089984988.USD","IBB","BK4533","LU2112291526.USD","LU1571399168.USD","PBE","LU2468319806.SGD","IE00BJT1NW94.SGD","LU0889565916.HKD","BK4599","TBXU","IBBQ","BIB","BK4534","LU0868494617.USD","LU1983299246.USD","LU2242646821.SGD","BK4139","IE00BFTCPJ56.SGD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663249076","title":"Amgen Repatha reduces risk of death in high-risk adults for first heart attack","url":"https://stock-news.laohu8.com/highlight/detail?id=2663249076","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663249076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:10","pubTimestamp":1788167413,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) announced new findings showing Repatha reduced the risk of death in high-risk adults without a prior heart attack or stroke when added...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amgen-repatha-reduces-risk-of-death-in-high-risk-adults-for-first-heart-attack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0889565916.HKD","IE0009355771.USD","IE00BJT1NW94.SGD","LU2242646821.SGD","TBXU","BK4581","IE00B2B36J28.USD","BIB","PJP","LU2242652126.USD","IE00B4R5TH58.HKD","LU2089984988.USD","BK4585","LU1571399168.USD","BK4533","IBBQ","AMGN","BK4566","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU1057294990.SGD","IE0002141913.USD","BK4599","BK4588","LU0868494617.USD","LU0320765992.SGD","LU0058720904.USD","LU0122379950.USD","LU2468319806.SGD","LU1983299246.USD","SG9999001440.SGD","LU0289739699.SGD","IE00BFTCPJ56.SGD","IBB","LU0109394709.USD","LU2112291526.USD","PBE","LU1061106388.HKD","BBH","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663753250","title":"Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2663753250","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663753250?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:33","pubTimestamp":1788165205,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has shared an announcement. Chimeric Therapeutics Limited is a biotechnology company focused on cell-based...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-posts-deeper-loss-as-ip-impairments-push-it-into-net-liabilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-posts-deeper-loss-as-ip-impairments-push-it-into-net-liabilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4585","DARP","BK4588","FHLC","BK4539","LNGR","IBB","BBP","LENZ","SYNB","BK4007","BK4139","IEIH","JDOC","AGNG","FWD","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663202044","title":"Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke","url":"https://stock-news.laohu8.com/highlight/detail?id=2663202044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663202044?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:18","pubTimestamp":1788160736,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nTUA6XK0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1983299246.USD","LU0320765992.SGD","BK4534","LU1023059063.AUD","LU0058720904.USD","LU0122379950.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IBBQ","BK4599","LU2468319806.SGD","PJP","BK4585","BK4588","IE0009355771.USD","LU0289739699.SGD","LU1057294990.SGD","SG9999001440.SGD","LU0889565916.HKD","BK4533","LU2242652126.USD","AMGN","LU2242646821.SGD","IE00BJJMRZ35.SGD","PBE","LU2089984988.USD","TBXU","LU1061106388.HKD","BBH","BK4139","BK4581","IBB","IE00BJT1NW94.SGD","LU0868494617.USD","LU2112291526.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1571399168.USD","BIB","LU0109394709.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663588047","title":"Protagonist announces Takeda received U.S. FDA approval for MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663588047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663588047?lang=en_us&edition=fundamental","pubTime":"2026-08-31 04:35","pubTimestamp":1788122107,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics (PTGX) announced that Takeda (TAK) received U.S. Food and Drug Administration, FDA, approval for MIMRYLO, a subcutaneously...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/protagonist-announces-takeda-received-u-s-fda-approval-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","PTGX","PSCH","IDNA","IBB","MRNX","GNMX","BK4588","LFSC","TAK","PINK","BK4139","GDOC","BMED","SYNB","BK4585","IEIH","MEDI","TBXU","FRTY","IYH","LABU","TECB","RSPH","BK4007","XLVX","BBP","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663043488","title":"Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043488","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043488?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:30","pubTimestamp":1788046226,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap.\n\nOver 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing.\nThe...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2468319806.SGD","LU0289739699.SGD","LU1839511570.USD","IBB","BK4583","LU0114720955.EUR","TBXU","LU1571399168.USD","LU1934455194.USD","LU1430594728.SGD","BMED","SG9999015978.USD","LU0965509010.AUD","BIB","LU1066051498.USD","LU2089984988.USD","LU0882574055.USD","BK4532","LU1934455863.HKD","LU1934455277.USD","IE00B19Z3B42.SGD","BBH","BK4566","LU0234570918.USD","BK4585","LU2112291526.USD","LU0058720904.USD","IBBQ","BK4568","LU1061106388.HKD","MEDI","BK4139","IE00BKVL7J92.USD","LU0965509283.SGD","LU1023059063.AUD","LU2324357040.USD","BK4588","BK4550","LU0823416689.USD","GILD","LU0965508806.USD","LU1066053197.SGD","IE00B3T34201.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","LU0109394709.USD","LU0122379950.USD","BK4578","TMED","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","MRNY","NVIB","IDNA","GNMX","IEIH","XLVX","SYNB","TECB","LFSC","GDOC","IYH","PSCH","MEDI","FRTY","IBB","BMED","RSPH","BBP","MRNX","BK4585","PINK","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYH","MRNX","RSPH","BK4007","LFSC","BK4588","TAK","MEDI","IBB","SYNB","FRTY","XLVX","IDNA","BK4585","GDOC","TECB","BBP","MRNY","PINK","LABU","IEIH","NVIB","BMED","GNMX","PSCH","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015099","title":"Crinetics Shareholders Approve Vertex Acquisition at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015099","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015099?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:33","pubTimestamp":1787952818,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals ( ($CRNX) ) has provided an update. On August 28, 2026, Crinetics Pharmaceuticals shareholders held a special meeting at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","BK4585","BIB","LU0256863811.USD","LU1069344957.HKD","LU2362540622.SGD","LU0289739699.SGD","IBBQ","LU1674673691.USD","VRTX","LU0079474960.USD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU0432979614.USD","LU2417539215.USD","BBH","LU0234570918.USD","TBXU","IE00BJT1NW94.SGD","LU0757428866.USD","LU1430594728.SGD","LU2236285917.USD","VERX","IE00BJJMRZ35.SGD","BK4023","BK4567","LU0823416689.USD","IE0009355771.USD","IDNA","IE00BZ9MQY76.HKD","IE00BFTCPJ56.SGD","BK4588","LU0061475181.USD","IE00B19Z3581.USD","LU2462157665.USD","LU2324357040.USD","GNMX","IE0002141913.USD","LU1674673428.USD","PBE","LU1093756168.USD","LU1815336091.USD","LU0566484027.USD","IE00B19Z9P08.USD","SG9999001176.SGD","BK4532","IE00B894F039.SGD","LU2468319806.SGD","LU1778281490.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}